drugset

drugset / Trial / NCT00865670

To Demonstrate the Relative Bioavailability of Azithromycin 600 mg Tablets Under Fed Conditions

NCT00865670 ↗

Phase 1 Completed 38 enrolled Sandoz

RandomizedCrossoverOpen-labelTreatment

Summary

To demonstrate the bioequivalence of Azithromycin 600 mg Tablets Under Fed Conditions.

Timeline

Start: 2003-08
Primary completion: 2003-09
Completion: 2003-09

Drugs

Evaluation	Drug	Modality	Dose	Route
Comparator	Azithromycin	Small molecule	600 mg	—

Indications